Equipotency of insulin glargine 300 and 100 U/mL with intravenous dosing but differential bioavailability with subcutaneous dosing in dogs

AIMS: Insulin glargine 300 U/mL (Gla‐300) contains the same units versus glargine 100 U/mL (Gla‐100) in three‐fold lower volume, and higher subcutaneous (SC) doses are required in people with diabetes. To investigate blood glucose (BG) lowering potency, Gla‐300 and Gla‐100 were compared after intrav...

Descripción completa

Detalles Bibliográficos
Autores principales: Werner, Ulrich, Tennagels, Norbert, Fanelli, Carmine G., Bolli, Geremia B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821234/
https://www.ncbi.nlm.nih.gov/pubmed/33001554
http://dx.doi.org/10.1111/dom.14212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821234/
https://www.ncbi.nlm.nih.gov/pubmed/33001554
http://dx.doi.org/10.1111/dom.14212

Ejemplares similares